Jean-François Crépault

Mr. Jean-François Crépault

orcid

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 January 2023 in International Journal of Drug Policy
Verified
Journal Article
Open access
JCJean-François Crépault
Jean-François Crépault
CRCayley Russell
Cayley Russell
TWTara Marie Watson
Tara Marie Watson
CSCarol Strike
Carol Strike
SBSarah Bonato
Sarah Bonato
JRJürgen Rehm
Jürgen Rehm
Psychoactive substance use and the regulations that govern it both have the potential to lead to harm. A 'public health approach' (PHA) is frequently invoked as a means of addressing these harms, but the term is used in inconsistent and contradictory ways. This study systematically reviewed the English-language academic literature to understand how a public health approach to substance use is defined and described. This review employed thematic synthesis, a methodology designed to rigorously synthesize qualitative evidence. Eligible articles were published in peer-reviewed journals, in the English language, with full text available, and focused primarily on substance use. There were no limits on year of publication. Original research, opinion/commentary, and reviews were included. The searches were conducted in October 2021 in CINAHL, Embase, Medline, PAIS Index, PsycINFO, Scopus, Sociological Abstracts, and Web of Science. 272 articles from 25 countries, published between 1950 and 2021, were synthesized. Definitions of a PHA have changed over time and differ by substance. The most commonly cited characteristics of a PHA were: for alcohol, regulation, e.g. of price and availability (54% of articles); for cannabis: regulation (68%); for illicit drugs: that a PHA is distinct from a criminal justice approach (63%); for opioids: substance use disorder treatment (55%); and for tobacco: regulation (62%). There is no consensus on the definition of a public health approach to substance use, but there is substantial agreement when it comes to PHAs to specific substances. There are also similarities in how they are described for legal substances versus illicit ones. This review found areas of disagreement regarding the extent to which PHAs should focus on individual-level factors. Policymakers, academics, and others developing or implementing PHAs to substance use should be explicit about their aims and objectives - as well as the premises and assumptions underlying them.

1 August 2016 in International Journal of Drug Policy
Verified
Journal Article
Closed access
JCJean-François Crépault
Jean-François Crépault
JRJürgen Rehm
Jürgen Rehm
BFBenedikt Fischer
Benedikt Fischer

6 August 2018 in Frontiers in Public Health
Verified
Journal Article
Open access
PDF file
JCJean-François Crépault
Jean-François Crépault
The Canadian government is “taking a public health approach to legalizing, strictly regulating and restricting access to cannabis.” There is, however, no universally accepted definition of a public health approach to cannabis. This paper presents what such an approach is, and is not, and discusses its applicability to legal psychoactive substances more generally. It critically reflects on the role of the public health sector in the governance of addictive substances and activities, noting its function of “responsibilizing” individuals and coaxing them to self-regulate—and the contradiction involved when other state actors involved in governance are actively inciting consumption of those substances and activities.

JRJürgen Rehm
Jürgen Rehm
JCJean-François Crépault
Jean-François Crépault
OHOmer S.M. Hasan
Omer S.M. Hasan
Dirk W. LachenmeierDirk W. Lachenmeier
Dirk W. Lachenmeier
RRRobin Room
Robin Room
BSBundit Sornpaisarn
Bundit Sornpaisarn
The object of this contribution based on a systematic review of the literature is to examine to what degree the level of use and potency play a role in regulatory policies for alcohol, other psychoactive substances and gambling, and whether there is an evidence base for this role. Level of use is usually defined around a behavioural pattern of the user (for example, cigarettes smoked per day, or average ethanol use in grams per day), while potency is defined as a property or characteristic of the substance. For all substances examined (alcohol, tobacco, opioids, cannabis) and gambling, both dimensions were taken into consideration in the formulation of most regulatory policies. However, the associations between both dimensions and regulatory policies were not systematic, and not always based on evidence. Future improvements are suggested.

9 November 2024 in International Journal of Drug Policy
Verified
Journal Article
Closed access
JCJean-François Crépault
Jean-François Crépault
BEBrian Emerson
Brian Emerson
EHElaine Hyshka
Elaine Hyshka
CSCarol Strike
Carol Strike
RRRobin Room
Robin Room
JRJürgen Rehm
Jürgen Rehm

1 November 2021 in International Journal of Drug Policy
Verified
Journal Article
Closed access
JCJean-François Crépault
Jean-François Crépault
JRJürgen Rehm
Jürgen Rehm
RRRobin Room
Robin Room